Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis

被引：0
|
作者：
Felson, David T. [1 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA 02215 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 17期
关键词：
WEIGHT-LOSS;
D O I：
10.1056/NEJMe2409972
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1643 / 1644
页数：2
相关论文
共 50 条
  • [21] Unravelling the ties that bind: The intersection of obesity, osteoarthritis, and inflammatory pathways with emphasis on glucagon-like peptide-1 agonists
    Jamal, Naadir
    Hollabaugh, William
    Scott, Leon
    Takkouche, Sahar
    CLINICAL OBESITY, 2025, 15 (01)
  • [22] Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists
    Christensen, Rasmus M.
    Juhl, Christian R.
    Torekov, Signe S.
    DRUG SAFETY, 2019, 42 (08) : 957 - 971
  • [23] Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists
    Cimino, Giuliana
    Vaduganathan, Muthiah
    Lombardi, Carlo M.
    Pagnesi, Matteo
    Vizzardi, Enrico
    Tomasoni, Daniela
    Adamo, Marianna
    Metra, Marco
    Inciardi, Riccardo M.
    ESC HEART FAILURE, 2024, 11 (02): : 649 - 661
  • [24] It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
    Oberle, Megan M.
    Kelly, Aaron S.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [25] Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity
    Jepsen, Mathies M.
    Christensen, Mikkel B.
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (03) : 231 - 243
  • [26] Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management
    Taha, Mohamad B.
    Yahya, Tamer
    Satish, Priyanka
    Laird, Rachel
    Agatston, Arthur S.
    Cainzos-Achirica, Miguel
    Patel, Kershaw V.
    Nasir, Khurram
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (08) : 643 - 654
  • [27] Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management
    Mohamad B. Taha
    Tamer Yahya
    Priyanka Satish
    Rachel Laird
    Arthur S. Agatston
    Miguel Cainzos-Achirica
    Kershaw V. Patel
    Khurram Nasir
    Current Atherosclerosis Reports, 2022, 24 : 643 - 654
  • [28] Glucagon-Like Peptide-1 Receptor Agonist Treatment for Pediatric Obesity
    Kelly, Aaron S.
    ADVANCED THERAPIES IN PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY, 2016, 30 : 23 - 28
  • [29] Glucagon-like peptide-1 receptor agonist use in pregnancy: a review
    Drummond, Rosa F.
    Seif, Karl E.
    Reece, Albert
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2025, 232 (01) : 17 - 25
  • [30] The Effects of Glucagon-Like Peptide-1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review
    Old, Victoria J.
    Davies, Melanie J.
    Papamargaritis, Dimitris
    Choudhary, Pratik
    Watson, Emma L.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (01)
12345